Floragenex

Eugene, United States Founded: 2006 • Age: 20 yrs Acquired By Sedia Biosciences
Genomic-based products and services are provided for research purposes.

About Floragenex

Floragenex is a company based in Eugene (United States) founded in 2006 was acquired by Sedia Biosciences in October 2016.. Floragenex offers products and services including RAD-Seq, SBG/ddRAD Sequencing, WGS, MethylRAD, and RNASeq. Floragenex operates in a competitive market with competitors including Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others.

  • Headquarter Eugene, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Floragenex, Inc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    IFSI

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    Sedia Biosciences

    (Oct 19, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Floragenex

Floragenex offers a comprehensive portfolio of products and services, including RAD-Seq, SBG/ddRAD Sequencing, WGS, MethylRAD, and RNASeq. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Fractional genome sequencing for genetic variants interrogation.

Identifies and scores variants across genomes for research.

Full genome interrogation for comprehensive analysis.

Focused sequencing of methylated sites in genomes.

Sequences expressed RNAs to study gene expression.

Multiplexed sequencing of specific genetic loci.

Funding Insights of Floragenex

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (08 Sep 2008)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2010 Amount Seed - Floragenex Valuation

investors

Sep, 2008 Amount Grant - Floragenex Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Floragenex

Floragenex has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include IFSI, Sedia Biosciences and ONAMI. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Startup accelerator
Founded Year Domain Location
Sweet corn and field crops research, product development, licensing and production company
Founded Year Domain Location
Point-of-care HIV diagnostic assays and surveillance tools are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Floragenex

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Floragenex

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Floragenex Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Floragenex

Floragenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genome sequencing platform is provided for clinical diagnostics.
domain founded_year HQ Location
New genome engineering technology is provided for treating multiple diseases.
domain founded_year HQ Location
DNA-encoded libraries are developed for drug discovery applications.
domain founded_year HQ Location
Laboratory and computational services for DNA proximity analysis are provided.
domain founded_year HQ Location
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
domain founded_year HQ Location
Genomic services and solutions with NGS expertise are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Floragenex

Frequently Asked Questions about Floragenex

When was Floragenex founded?

Floragenex was founded in 2006 and raised its 1st funding round 2 years after it was founded.

Where is Floragenex located?

Floragenex is headquartered in Eugene, United States. It is registered at Eugene, Oregon, United States.

What does Floragenex do?

Provider of genomic-based products and services for research purposes. They have two technology platforms -RAD-SEQ AND SBG DD-RAD-SEQ (Identify thousands to tens of thousands of genetic variants in a single NGS study using restriction enzymes in combination with NGS) and ION AMPLISEQ (For targeted sequencing and genotyping of hundreds of genetic variants with Ion Torrent sequencing platforms). Floragenex uses RAD sequencing (RAD-Seq) and double digest RAD sequencing (SBG ddRAD-Seq) as strategies to identify single nucleotide polymorphisms (SNPs). For detecting microsatellite (SSRs) variants, Floragenex offers Geno Sat technology in collaboration with their partners at GenoScreen. Floragenex also offers NGS-based methods for genotyping. Floragenex uses a cloud-based bioinformatics pipeline, built on AWS cloud to interpret next-gen sequencing data.

Who are the top competitors of Floragenex?

Floragenex's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.

What products or services does Floragenex offer?

Floragenex offers RAD-Seq, SBG/ddRAD Sequencing, WGS, MethylRAD, and 2 more products and services.

Who are Floragenex's investors?

Floragenex has 3 investors. Key investors include IFSI, Sedia Biosciences, and ONAMI.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available